Jan 22 (Reuters) - VALBIOTIS SAS:
* VALBIOTIS ANNOUNCES A SIGNIFICANT EFFECT OF VALEDIA® ON INTESTINAL MICROBIOTA
* VALEDIA(®) ACTS ON MICROBIOTA IMBALANCES ASSOCIATED WITH METABOLIC DISEASES (PRECLINICAL)
* ADDITIONAL DATA STRENGTHENS VALUE OF VALEDIA FOR PREVENTING TYPE 2 DIABETES
* VALBIOTIS CONTINUES ITS METAGENOMICS PROGRAM TO ASSESS HOW ITS PRODUCTS AFFECT MICROBIOTA Source text for Eikon: Further company coverage: (Gdynia Newsroom)
 